Document Detail


Evaluation of a porcine internal mammary artery (No-React II) as a small-diameter conduit.
MedLine Citation:
PMID:  9930429     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The patency of biologic small-diameter vascular grafts in the aortocoronary position is still unsatisfactory. Most of the studies suggest that xenografts are to be avoided as an aortocoronary bypass. METHODS: The porcine internal mammary artery treated by the No-React II procedure was developed for use as an alternative coronary artery bypass conduit. The attempt of this study was to evaluate the patency and histologic changes of the porcine internal mammary artery in animals. Five calves underwent coronary artery bypass grafting with a porcine internal mammary artery graft to the right coronary artery. After euthanasia of the animals 103 days later, the samples of these grafts were studied morphologically for patency, structural changes, calcifications, and inflammatory and immunologic response. RESULTS: One animal died during the procedure as result of acute thrombosis of the porcine internal mammary artery graft. In the other 4 animals all grafts became occluded. In the histologic sections of the grafts we noted multiple calcifications and a host-graft immunologic reaction (severe chronic rejection). CONCLUSIONS: The present study demonstrates a very poor experience with the porcine internal mammary artery (No-React II) conduit. We do not recommend this prosthesis for clinical use in humans.
Authors:
S Ostapczuk; J Poniewierski; A Thiel; H J Knieriem; T Orlowski; G Rakhorst; A Krian
Related Documents :
9495299 - Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clin...
11326229 - Facilitated coronary anastomosis using a nitinol u-clip device: bovine model.
14735049 - Coronary artery bypass grafting in dextrocardia with situs inversus totalis.
16953169 - Complete arterial revascularization in coronary artery bypass grafting in a patient wit...
8574019 - Video assisted coronary bypass surgery.
20731269 - Endovascular coiling of an internal mammary artery pseudoaneurysm following placement o...
18289019 - Chronic cerebral hypoperfusion protects against acute focal ischemia, improves motor fu...
3159939 - Management of congenital stenosis of a branch pulmonary artery with balloon dilation an...
24679739 - Detection of coronary artery disease using coronary flow velocity reserve by transthora...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  66     ISSN:  0003-4975     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  1998 Dec 
Date Detail:
Created Date:  1999-02-18     Completed Date:  1999-02-18     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  S115-7     Citation Subset:  AIM; IM    
Affiliation:
Clinic for Thoracic and Cardiovascular Surgery, Heart Centre KWK, Duisburg, Germany. stefan.ostapczuk@t-online.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Bioprosthesis* / adverse effects
Blood Vessel Prosthesis* / adverse effects
Blood Vessel Prosthesis Implantation / adverse effects
Calcinosis / etiology,  pathology
Cattle
Coronary Artery Bypass / adverse effects,  instrumentation*
Evaluation Studies as Topic
Foreign-Body Reaction / etiology,  pathology
Graft Occlusion, Vascular / etiology
Graft Rejection / etiology,  pathology
Hyperplasia
Internal Mammary-Coronary Artery Anastomosis / adverse effects,  instrumentation
Lymphocytes / pathology
Mammary Arteries
Prosthesis Design
Surface Properties
Survival Rate
Thrombosis / etiology
Tunica Intima / pathology
Vascular Patency

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Endothelialization of biosynthetic vascular prostheses after laser perforation.
Next Document:  Medtronic intact porcine bioprosthesis: 10 years' experience.